Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
11
×
biotech
boston blog main
life sciences
national blog main
boston top stories
startups
clinical trials
deals
investing
national top stories
new york blog main
venture capital
fda
financing
medical device
new york top stories
funding
perceptive advisors
series a
third rock ventures
20/20 healthcare partners
480 biomedical
abbott laboratories
abbvie
access biotechnology
access industries
adel malek
akero therapeutics
allosteric
ally bridge group
amgen ventures
amyotrophic lateral sclerosis
anemia
anthony despasqua
antisense oligonucleotide
apellis pharmaceuticals
aragon pharmaceuticals
arsenal medical
atlas venture
What
new
11
×
medicines
based
biotech
company
drugs
ipo
million
raised
therapeutics
address
aims
approach
body
called
cells
develop
developing
device
disease
diseases
genetic
lead
medicine
neuro
raises
research
set
tests
treatments
turn
absorb
adds
advance
ago
allosteric
analysis
anemia
associated
athletes
Language
unset
11
×
Current search:
boston
×
unset
×
new
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@techcrunch.com
4 years ago
Obvious Ventures makes CBD sporty with beam, which sells cannabis products to the GNC set
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further